Tecvayli® (also known as teclistamab-cqyv, its generic drug name) is an immunotherapy that enhances a patient’s own immune system to attack myeloma cells. This booklet explains who can be treated with Tecvayli, how it works, how it is given, and how side effects that may occur in patients treated with Tecvayli can be prevented or minimized.
